chronic
obstruct
pulmonari
diseas
copd
diseas
character
airflow
limit
progress
diseas
fulli
revers
world
health
organ
predict
copd
third
lead
caus
death
worldwid
tissu
patient
copd
character
chronic
inflamm
mucu
metaplasia
alveolar
destruct
structur
cell
apoptosi
inflamm
import
factor
develop
copd
inflamm
patient
may
causal
relat
emphysema
patholog
alter
lung
worsen
diseas
progress
pulmonari
inflamm
might
advers
impact
variou
extrapulmonari
organ
blood
vessel
heart
progress
pulmonari
inflamm
copd
innat
immun
adapt
immun
system
involv
howev
specif
mechan
still
elus
particularli
true
innat
immun
system
whose
role
unknown
inflamm
respons
copd
innat
immun
first
line
defens
foreign
pathogen
role
airway
involv
detect
molecular
pattern
pamp
damp
pattern
recognit
receptor
prr
includ
receptor
tlr
retino
acid
induc
gene
receptor
rlr
latent
infect
adenovirus
childhood
promot
chronic
inflamm
thu
gradual
lead
copd
recent
studi
demonstr
varieti
virus
caus
exacerb
diseas
compar
exacerb
due
caus
copd
exacerb
sever
last
longer
associ
airway
system
inflammatori
respons
rlr
newli
discov
pattern
recognit
receptor
play
critic
role
elimin
viral
infect
rlr
includ
melanoma
differenti
associ
gene
laboratori
genet
physiolog
rlr
local
within
cytoplasm
viral
rna
bind
regulatori
domain
initi
signal
cascad
lead
activ
nuclear
transloc
transcript
factor
need
turn
transcript
interferon
ifn
lack
caspas
activ
recruit
domain
incap
interferon
product
trigger
activ
intracellular
signal
pathway
culmin
induct
antivir
cytokin
mediat
rais
pivot
question
whether
involv
copd
pathogenesi
studi
assess
express
peripher
blood
mononuclear
cell
pbmc
bronchial
tissu
copd
patient
demonstr
copd
patient
significantli
differ
express
level
rlr
inflammatori
cytokin
thu
may
defin
critic
role
rlr
copd
airway
inflamm
peripher
blood
copd
patient
health
control
subject
respect
obtain
outpati
physic
examin
center
ruijin
hospit
affili
shanghai
jiaotong
univers
china
endobronchi
biopsi
copd
patient
control
subject
recruit
ward
respiratori
medicin
ruijin
hospit
bronchoalveolar
lavag
bal
copd
patient
control
subject
perform
infus
ml
steril
sodium
chlorid
either
middl
lingula
lobe
diagnosi
copd
made
accord
guidelin
global
initi
chronic
obstruct
lung
diseas
subject
stabl
condit
time
studi
control
subject
normal
lung
function
exclus
criteria
includ
current
recent
past
month
respiratori
tract
infect
exacerb
respiratori
diseas
cours
oral
steroid
antibiot
previou
month
particip
detail
shown
tabl
studi
review
approv
ethic
committe
ruijin
hospit
written
inform
consent
obtain
subject
immunohistochemistri
use
analyz
protein
level
bronchial
tissu
copd
control
patient
forti
biopsi
obtain
subject
specimen
use
immunohistochemistri
analysi
briefli
lung
section
endobronchi
biopsi
embed
paraffin
section
follow
dewax
xylen
rehydr
endogen
peroxidas
inhibit
hydrogen
peroxid
methanol
min
slide
incub
overnight
rabbit
polyclon
immunoglobulin
g
igg
antibodi
immunodetect
perform
biotinyl
goat
igg
reagent
horseradish
peroxidas
hrp
reagent
diaminobenzidin
blood
sampl
collect
heparin
evacu
test
tube
bd
vacutain
system
plymouth
uk
subject
pbmc
separ
peripher
blood
use
plu
sigma
shanghai
china
min
rpm
band
contain
pbmc
collect
transfer
new
tube
phosphat
buffer
salin
pb
ad
pbmc
pbmc
wash
three
time
centrifug
min
rpm
copd
patient
cell
count
higher
percentag
monocyt
lymphocyt
neutrophil
pbmc
control
group
total
rna
pbmc
bronchial
tissu
extract
use
rneasi
kit
qiagen
hilden
germani
qualiti
quantiti
obtain
rna
determin
spectrophotometri
base
absorb
one
microgram
total
rna
sampl
use
oligo
dt
primer
synthesi
cdna
revertaidtm
first
strand
cdna
synthesi
kit
fermenta
burlington
canada
pcr
perform
fast
pcr
system
appli
biosystem
foster
citi
ca
usa
faststart
univers
sybr
green
roch
basel
switzerland
cdna
synthesi
pcr
condit
follow
initi
denatur
min
follow
cycl
amplif
standard
curv
quantif
made
use
modifi
procedur
previous
describ
sequenc
primer
shown
tabl
fold
chang
gene
express
calcul
rel
intern
refer
gene
dehydrogenas
gapdh
mean
sampl
pbmc
isol
peripher
blood
lyse
lysi
buffer
mm
nacl
mm
ph
mm
ethylen
diamin
tetraacet
acid
sodium
dodecyl
sulfat
deoxycholat
mm
phenylmethanesulfonyl
fluorid
protein
concentr
quantifi
use
bca
protein
assay
kit
thermo
scientif
rockford
il
usa
accord
manufactur
instruct
equal
amount
protein
resolv
sodium
dodecyl
gelelectrophoresi
transfer
onto
poli
vinyliden
fluorid
membran
membran
block
pb
contain
nonfat
milk
h
room
temperatur
incub
overnight
antibodi
cell
signal
beverli
usa
antibodi
abcam
cambridgeshir
uk
antibodi
cell
signal
membran
wash
three
time
min
salin
incub
goat
igg
antibodi
sigma
dilut
min
room
temperatur
wash
chemiluminesc
substrat
thermo
scientif
ad
membran
signal
detect
quantifi
enhanc
chemiluminesc
system
imagequ
mini
ge
fairfield
ct
usa
sampl
normal
data
repres
mean
standard
error
sem
tumor
necrosi
factor
tnf
concentr
bronchoalveolar
lavag
fluid
balf
determin
use
duoset
elisa
kit
r
system
minneapoli
mn
usa
accord
manufactur
instruct
result
present
mean
sem
perform
group
associ
variabl
assess
use
spearman
rank
correl
test
statist
analys
perform
use
spss
p
valu
consid
statist
signific
mainli
present
airway
epithelium
cell
fig
copd
patient
higher
express
level
bronchial
mucosa
compar
control
subject
fig
b
signific
differ
observ
two
group
fig
total
rna
isol
bronchial
biopsi
sampl
copd
subject
analyz
mrna
express
pcr
fig
fold
chang
mrna
level
copd
patient
control
subject
copdcontrol
show
signific
differ
p
fig
ratio
express
housekeep
gene
gapdh
significantli
higher
copd
subject
control
subject
copdcontrol
fold
chang
p
fig
result
consist
immunohistochemistri
result
illustr
fig
detect
pcr
mrna
level
significantli
higher
copd
subject
control
subject
copdcontrol
fold
chang
p
fig
similar
result
obtain
protein
level
assess
western
blot
fig
protein
level
pbmc
threefold
higher
copd
subject
control
subject
fig
wherea
mrna
level
almost
ident
group
copdcontrol
fold
chang
p
fig
similar
result
obtain
protein
level
pbmc
copdcontrol
fold
chang
p
fig
f
compar
control
subject
copd
patient
show
significantli
higher
mrna
express
level
peripher
blood
fig
level
assess
elisa
also
higher
balf
copd
patient
control
subject
fig
e
result
demonstr
persist
inflamm
system
airway
copd
patient
consist
previou
report
studi
found
neg
correl
mrna
level
pbmc
forc
expiratori
volum
pred
copd
patient
r
p
fig
howev
signific
correl
mrna
level
pbmc
pred
r
p
fig
signific
correl
mrna
level
bronchial
mucosa
pred
r
p
data
shown
mrna
level
bronchial
mucosa
pred
r
p
data
shown
furthermor
pbmc
mrna
level
posit
correl
mrna
level
pbmc
copd
patient
r
p
r
p
respect
fig
viral
infect
signific
caus
chronic
obstruct
pulmonari
diseas
copd
acut
exacerb
copd
compar
exacerb
due
caus
copd
exacerb
sever
last
longer
associ
airway
system
inflammatori
respons
structur
cell
especi
epitheli
cell
endothelium
fibroblast
take
part
airway
inflamm
patient
copd
suscept
viral
infect
one
half
case
copd
exacerb
associ
viral
infect
epidemiolog
survey
illustr
viral
infect
main
caus
copd
exacerb
top
four
caus
rhinoviru
rv
coronaviru
influenza
viru
respiratori
syncyti
viru
rlr
essenti
viru
recognit
cytoplasm
detect
dsrna
cytoplasm
link
molecul
via
mav
previou
studi
shown
human
implic
recognit
differ
group
rna
virus
subsequ
activ
pathway
result
product
cytokin
interferon
shown
recogn
wide
distinct
group
virus
preferenti
detect
varieti
virus
recognit
triphosph
group
genom
rna
influenza
paramyxoviru
flaviviru
contrast
recogn
long
dsrna
detect
dsrna
replic
intermedi
genom
dsrna
like
detect
dsrna
virus
includ
rv
reovirus
epidemiolog
survey
illustr
rv
posit
rna
viru
respons
major
copd
exacerb
copd
patient
rv
infect
caus
rapid
declin
lung
function
recent
studi
wang
colleagu
provid
evid
respons
recogn
rv
subsequ
activ
signal
pathway
caus
exagger
inflammatori
respons
copd
patient
increas
level
monocyt
chemotact
protein
bain
colleagu
found
compar
healthi
primari
bronchial
epitheli
pbec
pbec
copd
patient
express
larg
amount
antivir
agent
highli
suscept
apoptosi
respond
rv
infect
studi
found
compar
control
subject
basal
level
patient
copd
elev
balf
pbmc
result
consist
previous
report
increas
system
airway
cytokin
copd
patient
howev
show
first
time
basal
level
elev
bronchial
mucosa
pbmc
patient
copd
data
impli
exagger
inflammatori
respons
rv
infect
copd
patient
may
associ
high
level
airway
epitheli
cell
excess
copd
patient
activ
rv
could
lead
induct
cytokin
flood
cytokin
flood
effect
facilit
viral
clearanc
also
may
contribut
airway
inflamm
furthermor
found
copd
patient
strong
correl
among
mrna
level
cytokin
mrna
level
airflow
obstruct
sever
pbmc
correl
indic
may
import
receptor
influenc
diseas
outcom
result
perman
stimul
high
level
cytokin
signific
correl
mrna
level
bronchial
biopsi
pred
may
due
small
number
bronchial
biopsi
sampl
studi
particular
cell
type
present
know
major
cell
type
pbmc
lymphocyt
monocyt
major
cell
type
bronchial
biopsi
sampl
epitheli
cell
lymphocyt
monocyt
critic
compon
immun
system
fight
infect
adapt
intrud
produc
cell
induc
higher
inflammatori
respons
epitheli
cell
may
lead
differ
correl
bronchial
biopsi
pbmc
hand
chang
mrna
protein
level
copd
patient
differ
outcom
basal
level
may
due
diverg
reorgan
mechan
feedback
regul
two
receptor
recent
schneider
colleagu
report
mrna
level
enhanc
airway
epitheli
cell
copd
patient
rather
statist
signific
find
inconsist
result
heterogen
may
due
differ
genet
background
differ
exposur
virus
cigarett
smoke
environment
agent
summari
find
indic
upregul
bronchial
tissu
pbmc
copd
patient
upregul
may
particip
high
express
level
inflammatori
cytokin
importantli
express
level
neg
correl
pred
indic
may
play
critic
role
diseas
progress
thu
also
identifi
new
target
therapi
develop
modul
sever
respons
clinic
set
understand
molecular
mechan
underli
process
open
novel
avenu
treatment
copd
